The diagnostic sensitivity of [18F]FES PET/CT for the assessment of ER status in recurrent or metastatic lesions is good overall [25–31], which indicates a high sensitivity for diagnosing recurrent breast cancer in patients with a history of ER-positive primary breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.